HHLA2-KCTD12 axis: a potential mechanism regulating the biological functions of laryngeal squamous cell carcinoma
Authors:
Open Access
- 8 October 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1898263
Abstract
Background: Accumulating evidence suggests that aberrant HHLA2 expression is closely implicated not only in tumorigenesis, disease progression, and metastatic spread, but also in the intricate modulation of the tumor immune microenvironment. Nevertheless, the biological functions of HHLA2 and the molecular mechanisms underlying its action in laryngeal squamous cell carcinoma (LSCC) remain unexplored. Materials and methods: HHLA2 expression was systematically assessed in LSCC tumor specimens and matched adjacent tissues using multiplex immunofluorescence (mIHC). The functional consequences of HHLA2 silencing in LSCC cells were evaluated through a series of in vitro assays, including CCK-8–based proliferation analysis, wound-healing (scratch) assays, and invasion assays. Transcriptomic sequencing integrated with public database mining was subsequently performed to identify key target genes potentially governed by HHLA2 in regulating LSCC biological behavior. Furthermore, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Set Enrichment Analysis (GSEA) pathway analyses were conducted to delineate the signaling networks and molecular pathways through which HHLA2 might exert its regulatory effects in LSCC. Results: HHLA2 expression was significantly elevated in LSCC tumor tissues, and associated with poor prognosis in patients. Functional experiments revealed that suppression of HHLA2 leads to marked inhibition of LSCC cell proliferation, migration, and invasion, underscoring its essential role in sustaining malignant phenotypes. Mechanistically, we identified potassium channel tetrameric domain 12 (KCTD12) as a pivotal target of HHLA2 in mediating these oncogenic processes. Importantly, forced overexpression of KCTD12 effectively counterbalanced the inhibitory effects induced by HHLA2 depletion, thereby restoring proliferative, migratory, and invasive potential to LSCC cells. Furthermore, pathway enrichment analyses indicated that the TNF—NF-κB signalling pathway might serve as a key conduit through which HHLA2 orchestrated both tumor cell functions and immune regulatory mechanisms. The HHLA2-KCTD12 axis may regulate the phenotype of LSCC cells and reshape the tumor immune microenvironment through the TNF—NF-κB signaling pathway. Conclusions: HHLA2 enhanced the proliferative, migratory, and invasive capacities of LSCC cells and might contribute to immune microenvironment remodeling via modulation of TNF—NF-κB signaling through the HHLA2–KCTD12 axis.Keywords
Funding Information
- Natural Science Foundation of Changzhou Municipality (QN202403)
This publication has 44 references indexed in Scilit:
- HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathwayMolecular Carcinogenesis, 2024
- Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironmentCancer Cell, 2024
- Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9Cellular Immunology, 2023
- KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapyJournal of Advanced Research, 2022
- Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma CellsInflammation, 2021
- RETRACTED: KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signalingJournal of Clinical Laboratory Analysis, 2020
- HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survivalCancer Letters, 2019
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor FamilyImmunity, 2016
- Clinical implications of cancer stem cell-like side population cells in human laryngeal cancerTumor Biology, 2013
- Life After Total LaryngectomyJAMA Otolaryngology–Head & Neck Surgery, 2007